Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Uckun

Showing results (1-10 of 341) with videos related to

Pageof 35
Sort By:
Blood|August 15, 1996
Severe combined immunodeficient mouse models of human leukemiaF M Uckun
Current Pharmaceutical Design|September 20, 2001
Rationally designed anti-mitotic agents with pro-apoptotic activityF M Uckun
Blood|November 15, 1990
Regulation of human B-cell ontogenyF M Uckun
Biochemical Pharmacology|September 29, 1998
Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosisF M Uckun
British Journal of Haematology|November 1, 1993
Immunotoxins for the treatment of leukaemiaF M Uckun
Leukemia & Lymphoma|February 16, 2000
Histamine as an autocrine regulator of leukemic cell proliferationR Malaviya, F M Uckun
Acta Crystallographica. Section C, Crystal Structure Communications|September 14, 1999
Alpha-cyano-N-(2,5-dibromophenyl)-beta-hydroxybut-2-enamideS Ghosh, F M Uckun
Leukemia & Lymphoma|September 24, 1999
A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemiaY Messinger, F M Uckun
American Journal of Therapeutics|September 11, 2001
Leflunomide metabolite analogue alpha-cyano-beta-hydroxy-beta-methyl-N-[3-(trifluoromethyl)phenyl]propenamide inhibits IgE/FcepsilonRI receptor-mediated mast cell leukotriene release and allergic asthma in miceR Malaviya, F M Uckun
Leukemia|February 1, 1993
The current status of immunotoxins: an overview of experimental and clinical studies as presented at the Third International Symposium on ImmunotoxinsF M Uckun, A Frankel
Pageof 35

Showing results (1-10 of 341) with videos related to

Sort By:
Pageof 35
Blood|August 15, 1996
Severe combined immunodeficient mouse models of human leukemiaF M Uckun
Current Pharmaceutical Design|September 20, 2001
Rationally designed anti-mitotic agents with pro-apoptotic activityF M Uckun
Blood|November 15, 1990
Regulation of human B-cell ontogenyF M Uckun
Biochemical Pharmacology|September 29, 1998
Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosisF M Uckun
British Journal of Haematology|November 1, 1993
Immunotoxins for the treatment of leukaemiaF M Uckun
Leukemia & Lymphoma|February 16, 2000
Histamine as an autocrine regulator of leukemic cell proliferationR Malaviya, F M Uckun
Acta Crystallographica. Section C, Crystal Structure Communications|September 14, 1999
Alpha-cyano-N-(2,5-dibromophenyl)-beta-hydroxybut-2-enamideS Ghosh, F M Uckun
Leukemia & Lymphoma|September 24, 1999
A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemiaY Messinger, F M Uckun
American Journal of Therapeutics|September 11, 2001
Leflunomide metabolite analogue alpha-cyano-beta-hydroxy-beta-methyl-N-[3-(trifluoromethyl)phenyl]propenamide inhibits IgE/FcepsilonRI receptor-mediated mast cell leukotriene release and allergic asthma in miceR Malaviya, F M Uckun
Leukemia|February 1, 1993
The current status of immunotoxins: an overview of experimental and clinical studies as presented at the Third International Symposium on ImmunotoxinsF M Uckun, A Frankel
Pageof 35